Movement Disorder Market Forecast Report Showing Growth Opportunities and Trends Analysis through the Time Period from 2017 to 2026 with Market Classification by Product Type, End User Type, Application and Technology

The scope of FactMR’s report is to analyze the global movement disorder market for the forecast period 2017-2026 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global Movement Disorder Market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to movement disorder.

The report commences with a brief information of the global Movement Disorder Market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global movement disorder market.

Get Free Sample Report Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=329

Prevalence of the mental disorders has continued to remain high among the old aged population globally. Neurological diseases such as Huntington’s disease, Parkinson’s disease and multiple symptom atrophy (MSA) continues to propel demand for management of the movement disorders. Lack of production of brain chemical dopamine by the nerve cells in the brain leads to uncoordinated movements and mental disorders that impact the everyday activities of the persons.

Inability to generate movements affects the functioning of nerves, brain and the spinal cord adversely. Neurological disorders has led to surge in diseases such as trauma, convulsive diseases, cerebrovascular diseases, brain tumors and degenerative diseases. Growing prevalence of such mental disorders impact the cognitive abilities and lead to increasing prevalence of insomnia, depression, swallowing, inability to chew and speaking. Surge in awareness attributed to increasing prevalence of the neurological diseases is expected to impact growth of the global movement disorders market positively.

FDA Approval to Boost Sales of Medications

Medications and treatments approved by FDA is also expected to impact growth of the global movement disorder market. Xadago (safinamide) tablets and Ingrezza capsules are two drugs that have recently cleared the FDA pipeline. Ingrezza capsules have recently received approval for treatment of dyskinesia and Xadago (safinamide) tablets have received approval of Parkinson’s disease. In addition, the FDA has also approved implantation of brain to reduce the tremor symptoms. These factors are further expected to boost growth of the global movement disorders market.

Advanced Features to Impact Growth of the Global Market

In order to gain a competitive edge, various companies operating in the global movement disorder market are focusing on product innovation and developments. Manufacturers are mainly concentrating on incorporating advanced technology in the medical devices for faster recovery and improved results.

Browse Complete Report In-Depth Here - https://www.factmr.com/report/329/movement-disorder-market

Growing need for medical devices with the uninterrupted functioning for treatment of the neurological disorders has led to an upsurge in adoption of rechargeable deep brain stimulator devices. On the basis of product type, the rechargeable deep brain stimulator devices segment is expected to generate significant revenues, accounting for a value of over US$ 500 Mn by the end of 2026. However, the non-rechargeable deep brain stimulator devices product type segment is expected to register the highest CAGR during the forecast period.

Based on end user, the hospitals segment is expected to represent the highest revenue growth, recording a value of less than US$ 100 Mn by the end of 2017. On the other hand, the clinics end user segment is expected to register a robust through 2026.

By application, the Parkinson’s disease segment is expected to represent a significant revenue growth, accounting for a value of over US$ 400 Mn by the end of 2026. In contrary to this, the dystonia application segment is expected to register a healthy CAGR throughout the forecast period.

Competition Tracking

Leading market players operating in the global movement disorder market include Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation and Mayo Clinic.

Table of Contents

Chapter 1 Global Outlook

Chapter 2 Global Movement Disorder Market - Executive Summary

Chapter 3 Global Movement Disorder Market Overview

3.1 Introduction

      3.1.1 Global Movement Disorder Market Taxonomy

      3.1.2 Global Movement Disorder Market Definition

3.2 Global Movement Disorder Market Size (US$ Mn) and Forecast, 2012-2026

      3.2.1 Global Movement Disorder Market Y-o-Y Growth

3.3 Global Movement Disorder Market Dynamics

3.4 Supply Chain

3.5 Cost Structure

3.6 Technology Roadmap

3.7 Disease Epidemiology

3.8 Product Lifecycle

3.9 Key Regulations

3.10 PESTL Analysis

3.11 List of Service Providers

3.12 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Movement Disorder Market Analysis and Forecast 2012-2026

4.1 Global Movement Disorder Market Size and Forecast by Product Type, 2012-2026

      4.1.1 Rechargeable Deep Brain Stimulator Devices Market Size and Forecast, 2012-2026

              4.1.1.1 Revenue (US$ Mn) Comparison, By Region

              4.1.1.2 Market Share Comparison, By Region

              4.1.1.3 Y-o-Y growth Comparison, By Region

Continued………………………………

Buy This Report from Here - https://www.factmr.com/checkout/329/S

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Sports market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us -

FactMR
Suite 9884
27 Upper Pembroke Street, Dublin 2, Ireland
Telephone @ +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/

This release was published on openPR.